marijuana stocks

ENDEXX Corp. (EDXC)

 
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013
Total Revenue 35   –   –   –  
Cost of Revenue
Gross Profit 35   –   –   –  
Operating Expenses
Research Development 50 64 2 0
Selling General and Administrative 252 178 99 64
Non Recurring
Others 0 0 0 0
Total Operating Expenses
Operating Income or Loss (268) (243) (101) (65)
Income from Continuing Operations
Total Other Income/Expenses Net 0 36 0 232
Earnings Before Interest And Taxes (267) (207) (333) 167
Interest Expense
Income Before Tax (267) (207) (333) 167
Income Tax Expense
Minority Interest
Net Income From Continuing Ops (267) (207) (333) 399
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (267) (207) (101) 167  
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (267) (207) (101) 167

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$ICBU to Give Upgraded Guidance on Revenues for 2017

iMD Companies Inc., to Give Upgraded Guidance on Revenues for 2017 and…

 The Supreme Cannabis Company, Inc. (SPRWF) (FIRE.TO) Launches Premium Cannabis Oil in Partnership with Wiz Khalifa

Supreme Cannabis Launches Premium Cannabis Oil in Partnership with Wiz Khalifa and…

1933 Industries’ (TGIF) (TGIFF) Canna Hemp X™ Recovery Cream Now Available at Zumiez Stores in the US

VANCOUVER, Sept. 23, 2019 /PRNewswire/ – 1933 Industries Inc. (the “Company” or…

Tetra Bio-Pharma Inc. (TBPMF) FDA Provides Positive Feedback on Pre-Investigational New Drug Application for ARDS-003

FDA Provides Positive Feedback on Tetra Bio-Pharma’s Pre-Investigational New Drug Application for…